Disseminating findings to participants at the end of the study. Most lung cancer patients will not be alive to see the results of our research studies. Patient continuity of representation on steering groups can be problematic. It may be useful to start a patient-caregiver reference group for the research (rather than having one user representative) and to report findings to local/national patient groups and charities. In my experience, patients do want to participate in research studies of all types and derive benefit from participation. The potential for nurses to contribute to the current research agenda on survivorship and supporting individuals affected by lung cancer is significant. In the last 2 years, a number of studies have been funded in the United Kingdom, specifically to develop interventions for lung cancer patients; this increase in research funding is welcome, and I hope that this ongoing research has an impact on practice and outcomes for patients and their caregivers in the future.
